Orthofix Medical Inc. Income Statement
OFIX|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$747M
FY2025
Gross Profit
$486M
65.1% gross margin
Operating Income
-$139M
FY2025
Net Income
-$151M
FY2025
Orthofix Medical Inc. reported $747M in revenue and $151M in net loss for FY2025. Revenue has grown at a 2.3% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Piotroski F-Score: 2/9 criteria passed
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $746.6M | $460.7M | $464.5M | $406.6M | $460.0M | $453.0M | $433.8M | $409.8M | $396.5M | $402.3M | $397.6M | $440.2M | $442.0M | $460.6M | $545.6M |
| Cost of Revenue | $260.4M | $123.5M | $114.9M | $101.9M | $100.6M | $96.6M | $93.0M | $87.9M | $86.5M | $98.9M | $106.9M | $100.7M | $95.5M | $90.5M | $138.4M |
| Gross Profit | $486.3M | $337.2M | $349.6M | $304.7M | $359.3M | $356.4M | $340.8M | $321.9M | $310.0M | $303.4M | $290.7M | $339.5M | $346.4M | $370.2M | $407.2M |
| SG&A Expense | $530.4M | $308.8M | $69.4M | $67.9M | $85.6M | $83.3M | $71.9M | $76.4M | $87.2M | $79.1M | $67.5M | $53.6M | $64.5M | $72.9M | $88.9M |
| R&D Expense | $80.2M | $49.1M | $49.6M | $39.1M | $34.6M | $33.2M | $29.7M | $28.8M | $26.4M | $25.0M | $26.8M | $28.6M | $22.9M | $28.0M | $31.5M |
| Operating Income | -$139.1M | -$13.3M | -$8.3M | -$6.3M | -$18.8M | $30.1M | $40.8M | $21.1M | $9.3M | $17.1M | -$11.2M | $74.9M | $5.9M | $66.3M | $63.9M |
| Interest Expense | -$8.6M | -$1.3M | -$1.8M | -$2.5M | -$122.0K | -$828.0K | -$416.0K | $763.0K | -$489.0K | -$1.8M | -$1.8M | $4.2M | $5.5M | $16.2M | $24.8M |
| Income Tax | $2.7M | $2.0M | $24.9M | -$2.9M | $1.4M | $9.1M | $29.1M | $15.5M | $10.8M | $16.2M | $7.6M | $23.9M | $14.2M | $22.6M | $15.5M |
| Net Income | -$151.4M | -$19.7M | -$38.4M | $2.5M | -$28.5M | $13.8M | $6.2M | $3.1M | -$2.8M | -$8.5M | -$28.8M | $42.9M | -$18.1M | $44.2M | -$35.8M |
| EPS (Basic) | -$4.12 | -$0.98 | -$1.95 | $0.13 | -$1.51 | $0.73 | $0.34 | $0.17 | -$0.15 | -$0.46 | -$0.46 | $2.26 | -$0.99 | $2.51 | $1.43 |
| EPS (Diluted) | -$4.12 | -$0.98 | -$1.95 | $0.13 | -$1.51 | $0.72 | $0.34 | $0.17 | -$0.15 | -$0.46 | -$0.46 | $2.21 | -$0.99 | $2.47 | $1.42 |
| Shares Outstanding | 38.5M | 37.2M | 20.2M | 19.8M | 19.4M | 19.0M | 18.6M | 18.3M | 17.8M | 18.7M | 18.6M | 18.1M | 19.3M | 18.5M | 17.7M |
| Gross Margin | 65.1% | 73.2% | 75.3% | 74.9% | 78.1% | 78.7% | 78.5% | 78.6% | 78.2% | 75.4% | 73.1% | 77.1% | 78.4% | 80.4% | 74.6% |
| Operating Margin | -18.6% | -2.9% | -1.8% | -1.5% | -4.1% | 6.6% | 9.4% | 5.1% | 2.3% | 4.3% | -2.8% | 17.0% | 1.3% | 14.4% | 11.7% |
| Profit Margin | -20.3% | -4.3% | -8.3% | 0.6% | -6.2% | 3.0% | 1.4% | 0.8% | -0.7% | -2.1% | -7.2% | 9.7% | -4.1% | 9.6% | -6.6% |